Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells
Ute E. Burkhardt, … , Edwin P. Alyea, Catherine J. Wu
Ute E. Burkhardt, … , Edwin P. Alyea, Catherine J. Wu
Published August 5, 2013
Citation Information: J Clin Invest. 2013;123(9):3756-3765. https://doi.org/10.1172/JCI69098.
View: Text | PDF
Clinical Research and Public Health Article has an altmetric score of 59

Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells

  • Text
  • PDF
Abstract

Background. Patients with advanced hematologic malignancies remain at risk for relapse following reduced-intensity conditioning (RIC) allogeneic hematopoietic stem cell transplantation (allo-HSCT). We conducted a prospective clinical trial to test whether vaccination with whole leukemia cells early after transplantation facilitates the expansion of leukemia-reactive T cells and thereby enhances antitumor immunity.

Methods. We enrolled 22 patients with advanced chronic lymphocytic leukemia (CLL), 18 of whom received up to 6 vaccines initiated between days 30 and 45 after transplantation. Each vaccine consisted of irradiated autologous tumor cells admixed with GM-CSF–secreting bystander cells. Serial patient PBMC samples following transplantation were collected, and the impact of vaccination on T cell activity was evaluated.

Results. At a median follow-up of 2.9 (range, 1–4) years, the estimated 2-year progression-free and overall survival rates of vaccinated subjects were 82% (95% CI, 54%–94%) and 88% (95% CI, 59%–97%), respectively. Although vaccination only had a modest impact on recovering T cell numbers, CD8+ T cells from vaccinated patients consistently reacted against autologous tumor, but not alloantigen-bearing recipient cells with increased secretion of the effector cytokine IFN-γ, unlike T cells from nonvaccinated CLL patients undergoing allo-HSCT. Further analysis confirmed that 17% (range, 13%–33%) of CD8+ T cell clones isolated from 4 vaccinated patients by limiting dilution of bulk tumor-reactive T cells solely reacted against CLL-associated antigens.

Conclusion. Our studies suggest that autologous tumor cell vaccination is an effective strategy to advance long-term leukemia control following allo-HSCT.

Trial registration. Clinicaltrials.gov NCT00442130.

Funding. NCI (5R21CA115043-2), NHLBI (5R01HL103532-03), and Leukemia and Lymphoma Society Translational Research Program.

Authors

Ute E. Burkhardt, Ursula Hainz, Kristen Stevenson, Natalie R. Goldstein, Mildred Pasek, Masayasu Naito, Di Wu, Vincent T. Ho, Anselmo Alonso, Naa Norkor Hammond, Jessica Wong, Quinlan L. Sievers, Ana Brusic, Sean M. McDonough, Wanyong Zeng, Ann Perrin, Jennifer R. Brown, Christine M. Canning, John Koreth, Corey Cutler, Philippe Armand, Donna Neuberg, Jeng-Shin Lee, Joseph H. Antin, Richard C. Mulligan, Tetsuro Sasada, Jerome Ritz, Robert J. Soiffer, Glenn Dranoff, Edwin P. Alyea, Catherine J. Wu

×

Total citations by year

Year: 2025 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2009 Total
Citations: 1 1 1 3 2 1 4 4 6 4 8 2 1 38
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2016 (6)

Title and authors Publication Year
Vaccination with Irradiated Autologous Tumor Cells Mixed with Irradiated GM-K562 Cells Stimulates Antitumor Immunity and T Lymphocyte Activation in Patients with Recurrent Malignant Glioma
WT Curry, R Gorrepati, M Piesche, T Sasada, P Agarwalla, PS Jones, ER Gerstner, AJ Golby, TT Batchelor, PY Wen, MC Mihm, G Dranoff
Clinical cancer research 2016
Wilms tumor 1 peptide vaccination after hematopoietic stem cell transplant in leukemia patients
N Hosen, T Maeda, Y Hashii, A Tsuboi, S Nishida, J Nakata, Y Oji, Y Oka, H Sugiyama
Stem Cell Investigation 2016
Advances in Experimental Medicine and Biology
NR Harrison, FJ Laroche, A Gutierrez, H Feng
Advances in experimental medicine and biology 2016
GIFT4 fusokine converts leukemic B cells into immune helper cells
J Deng, A Pennati, JB Cohen, Y Wu, S Ng, JH Wu, CR Flowers, J Galipeau
Journal of Translational Medicine 2016
Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade
M Lotem, S Merims, S Frank, T Hamburger, A Nissan, L Kadouri, J Cohen, R Straussman, G Eisenberg, S Frankenburg, E Carmon, B Alaiyan, S Shneibaum, ZO Ayyildiz, M Isbilen, KM Senses, I Ron, H Steinberg, Y Smith, E Shiloni, AO Gure, T Peretz
Journal of Immunology Research 2016
Deregulation of SOCS5 suppresses dendritic cell function in chronic lymphocytic leukemia
PA Toniolo, S Liu, JE Yeh, DQ Ye, JA Barbuto, DA Frank
Oncotarget 2016

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 8 news outlets
Posted by 8 X users
Referenced in 12 patents
On 1 Facebook pages
84 readers on Mendeley
1 readers on CiteULike
See more details